BBIO
NASDAQ · Biotechnology
Bridgebio Pharma Inc
$67.39
-0.06 (-0.09%)
Performance
1D
—
1W
—
1M
—
3M
-6.78%
6M
+1.22%
1Y
+88.87%
YTD
-13.86%
Open$66.53
Previous Close$67.45
Day High$69.11
Day Low$66.00
52W High$84.94
52W Low$31.77
Volume—
Avg Volume3.69M
Market Cap13.21B
P/E Ratio—
EPS$-3.78
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$75.38
Below
SMA 200
$56.39
Above
RSI (14)
38.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
28 analysts
Price Target
+182.0% upside
Current
$67.39
$67.39
Target
$190.06
$190.06
$141.92
$190.06 avg
$243.96
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 513.74M | 275.76M | 2.34B |
| Net Income | -741,786,423 | -358,350,928 | -436,239,166 |
| Profit Margin | -144.4% | -137.2% | -18.6% |
| EBITDA | -507,609,250 | -258,845,296 | -548,703,476 |
| Free Cash Flow | — | — | -421,297,535 |
| Rev Growth | +86.3% | +86.3% | -0.2% |
| Debt/Equity | 8.27 | 8.27 | 0.84 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |